HIV Env reduction postreceptor binding: a new target for AIDS treatment?

被引：4

作者：

Fenouillet, E ^{[1
]}

Barbouche, R ^{[1
]}

Jones, IM ^{[1
]}

机构：

[1] CNRS, Sch Med, Dept Biochem, F-13015 Marseille, France

来源：

BLOOD | 2004年 / 104卷 / 01期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1182/blood-2004-03-1176

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：296 / 296

页数：1

共 8 条

[1] Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion [J].

Barbouche, R ;

Miquelis, R ;

Jones, IM ;

Fenouillet, E .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3131-3136

[2] The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope- mediated membrane fusion after CD4 cell binding [J].

Fenouillet, E ;

Barbouche, R ;

Courageot, J ;

Miquelis, R .

JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (05) :744-752

[3] Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry [J].

Gallina, A ;

Hanley, TM ;

Mandel, R ;

Trahey, M ;

Broder, CC ;

Viglianti, GA ;

Ryser, HJP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) :50579-50588

[4]

KOMBLUTH RS, 2004, BLOOD, V103, P1567

[5] Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry [J].

Markovic, I ;

Stantchev, TS ;

Fields, KH ;

Tiffany, LJ ;

Tomiç, M ;

Weiss, CD ;

Broder, CC ;

Strebel, K ;

Clouse, KA .

BLOOD, 2004, 103 (05) :1586-1594

[6] Disulfide exchange in domain 2 of CD4 is required for entry of HIV-I [J].

Matthias, LJ ;

Yam, PTW ;

Jiang, XM ;

Vandegraaff, N ;

Li, P ;

Poumbourios, P ;

Donoghue, N ;

Hogg, PJ .

NATURE IMMUNOLOGY, 2002, 3 (08) :727-732

[7] A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) [J].

Morre, DJ ;

Jacobs, E ;

Sweeting, M ;

deCabo, R ;

Morre, DM .

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1325 (01) :117-125

[8] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY AGENTS THAT INTERFERE WITH THIOL-DISULFIDE INTERCHANGE UPON VIRUS-RECEPTOR INTERACTION [J].

RYSER, HJP ;

LEVY, EM ;

MANDEL, R ;

DISCIULLO, GJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4559-4563

← 1 →